Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion type Assertion NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_head.
- NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion description "[PAC (1) -R null variant is the most relevant isoform expressed in human prostaste cancer, and may be related with the events determining the outcome of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_provenance.
- NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion evidence source_evidence_literature NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_provenance.
- NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion SIO_000772 16372333 NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_provenance.
- NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion wasDerivedFrom lhgdn-20090331 NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_provenance.
- NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_assertion wasGeneratedBy ECO_0000203 NP168196.RAN9Pvm0Masf0Cqy7qmSvPzAb1VEYcGDNvT8Ron6tYljc130_provenance.